ORKA insider trades & Congress trades
Oruka Therapeutics, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 19 open-market insider transactions in Oruka Therapeutics, Inc. (ORKA) (0 purchases with code P and 19 sales with code S), the most recent on October 20, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 19 sales by 3 ($3.02M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | Quinlan Paul T | General Counsel | Sell | 400 | $74.90 | $30K | – |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | Sell | 500 | $76.12 | $38K | – |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | Sell | 1,000 | $77.21 | $77K | – |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | Sell | 4,100 | $78.79 | $323K | – |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | Sell | 3,000 | $79.49 | $238K | – |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | Sell | 2,853 | $73.89 | $211K | – |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | Sell | 1,847 | $74.69 | $138K | – |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | Sell | 1,400 | $75.48 | $106K | – |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | Sell | 700 | $76.67 | $54K | – |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | Sell | 200 | $77.71 | $16K | – |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 5,741 | $80.03 | $459K | – |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 2,100 | $80.76 | $170K | – |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 1,958 | $81.86 | $160K | – |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 200 | $82.84 | $17K | – |
| Sep 21, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 533 | $95.75 | $51K | – |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | Sell | 2,667 | $95.31 | $254K | – |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | Sell | 601 | $94.44 | $57K | – |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | Sell | 3,832 | $93.32 | $358K | – |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | Sell | 2,900 | $92.37 | $268K | – |
Data as of October 22, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.